King Faisal Specialist Hospital and Research Centre has been named the Middle East’s most valuable healthcare brand for the fourth consecutive year, with its brand value exceeding SR6.3 billion ($1.7 billion), according to the 2026 report by Brand Finance.
The institution also secured a position among Saudi Arabia’s top 10 most valuable brands, maintaining its standing for the third year in a row—an achievement that highlights the growing strength and competitiveness of specialized healthcare within the Kingdom’s broader economic landscape.
According to the report, KFSHRC topped the list of the Middle East’s most valuable healthcare brands, reinforcing its status as a regional benchmark in specialized care, medical research, education, and clinical innovation, supported by measurable medical and operational outcomes.
This recognition builds on a series of groundbreaking achievements in 2025, including the world’s first fully robotic artificial heart pump transplant, the first dual robotic implantation of ventricular assist devices, and the first robotic liver lobe transplant for a child.
The hospital also launched Saudi Arabia’s first genetic and cellular therapy manufacturing facility and reduced emergency department wait times by 75 percent, placing it among the top 5 percent of high-capacity academic medical centers globally.
These milestones demonstrate KFSHRC’s ability to translate medical, research, and operational innovation into tangible improvements in care quality, efficiency, and patient experience, aligning with the goals of Saudi Vision 2030 to strengthen the Kingdom’s global leadership in healthcare.
